Evidence map›Paper›PMID 39060644›Full record

ArticleHuman genetics2024

Chromosomal structural rearrangements implicate long non-coding RNAs in rare germline disorders.

Rebecca E Andersen, Ibrahim F Alkuraya, Abna Ajeesh, Tyler Sakamoto, Elijah L Mena, Sami S Amr, Hila Romi, Margaret A Kenna, Caroline D Robson, Ellen S Wilch and 4 more

Abstract read
In one paragraph

Article in Human genetics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Transcriptomic Convergence and the Female Protective Effect in Autism.bioRxiv : the preprint server for biology · 2025
    Article
  5. HeterozygousJournal of medical genetics · 2025
    Article
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Rebecca E AndersenDivision of Genetics and Genomics and Manton Center for Orphan Diseases, Boston Children's Hospital, Boston, MA, USA.ORCID http://orcid.org/0000-0002-0702-3120
Ibrahim F Alkuraya *Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, MA, USA.ORCID http://orcid.org/0000-0003-2489-2464
Abna Ajeesh *Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, MA, USA.ORCID http://orcid.org/0000-0002-9354-0190
Tyler SakamotoDivision of Genetics and Genomics and Manton Center for Orphan Diseases, Boston Children's Hospital, Boston, MA, USA.ORCID http://orcid.org/0009-0001-5972-8288
Elijah L MenaHarvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0001-9980-9018
Sami S AmrHarvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0003-0927-6057
Hila RomiHarvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0003-4071-4334
Margaret A KennaHarvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0003-0851-9272
Caroline D RobsonHarvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0001-5592-249X
Ellen S WilchDepartment of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, MA, USA.ORCID http://orcid.org/0009-0008-5381-5437
Katarena NalbandianDepartment of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, MA, USA.ORCID http://orcid.org/0000-0002-2617-7387
Raul Piña-AguilarHarvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0002-2043-4282
Christopher A WalshDivision of Genetics and Genomics and Manton Center for Orphan Diseases, Boston Children's Hospital, Boston, MA, USA.ORCID http://orcid.org/0000-0002-0156-2238
Cynthia C MortonHarvard Medical School, Boston, MA, USA. cmorton@bwh.harvard.edu.ORCID http://orcid.org/0000-0003-2198-6756

Funding

RAPID GENE DISCOVERYP01GM061354 · NIGMS · BRIGHAM AND WOMEN'S HOSPITAL · PI MORTON, CYNTHIA CASSON · 2001 to 2019
$24.3M
TRAINING GRANT IN GENETICST32GM007748 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI Anne O'Donnell-Luria, Louise Wilkins-Haug · 1985 to 2026
$12.0M
HUMAN EPILEPSY GENETICS--NEURONAL MIGRATION DISORDERSR01NS035129 · NINDS · BOSTON CHILDREN'S HOSPITAL · PI WALSH, CHRISTOPHER A. · 1997 to 2023
$9.5M
Characterization of a ubiquitin-independent pathway for proteasomal degradationK99AG081456 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI MENA, ELIJAH L · 2023 to 2024
$273k
NIA NIH HHS K99 AG081456NIA NIH HHS K99AG081456NIGMS NIH HHS P01 GM061354NIGMS NIH HHS T32 GM007748NIHR Manchester Biomedical Research Center NIHR203308NINDS NIH HHS 5R01NS035129NINDS NIH HHS R01 NS035129
6 · The paper itself

Abstract

In recent years, there has been increased focus on exploring the role the non-protein-coding genome plays in Mendelian disorders. One class of particular interest is long non-coding RNAs (lncRNAs), which has recently been implicated in the regulation of diverse molecular processes. However, because lncRNAs do not encode protein, there is uncertainty regarding what constitutes a pathogenic lncRNA variant, and thus annotating such elements is challenging. The Developmental Genome Anatomy Project (DGAP) and similar projects recruit individuals with apparently balanced chromosomal abnormalities (BCAs) that disrupt or dysregulate genes in order to annotate the human genome. We hypothesized that rearrangements disrupting lncRNAs could be the underlying genetic etiology for the phenotypes of a subset of these individuals. Thus, we assessed 279 cases with BCAs and selected 191 cases with simple BCAs (breakpoints at only two genomic locations) for further analysis of lncRNA disruptions. From these, we identified 66 cases in which the chromosomal rearrangements directly disrupt lncRNAs. In 30 cases, no genes of any other class aside from lncRNAs are directly disrupted, consistent with the hypothesis that lncRNA disruptions could underly the phenotypes of these individuals. Strikingly, the lncRNAs MEF2C-AS1 and ENSG00000257522 are each disrupted in two unrelated cases. Furthermore, we experimentally tested the lncRNAs TBX2-AS1 and MEF2C-AS1 and found that knockdown of these lncRNAs resulted in decreased expression of the neighboring transcription factors TBX2 and MEF2C, respectively. To showcase the power of this genomic approach for annotating lncRNAs, here we focus on clinical reports and genetic analysis of seven individuals with likely developmental etiologies due to lncRNA disruptions.

Indexed as

MEF2 Transcription FactorsRNA, Long NoncodingChromosome AberrationsFemaleGenome, HumanGerm-Line MutationHumansMalePhenotypeMEF2C protein, humanMEF2 Transcription FactorsRNA, Long Noncoding

Identifiers

PMID39060644
PMCPMC11294402

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.